The Tenth Taihu Lake Medicine Quality Assurance Forum was Held in Hualan NPM
On June 9, 2013, the “Tenth Taihu Lake Medicine Quality Assurance Forum” hosted by Wuxi Medicine Committee was held in Jiangsu Hualan New Pharmaceutical Material Co., Ltd.
This forum was hosted by the vice chairman and secretary-general of Wuxi Medicine Committee. Experts and representatives attending the forum are the guest professor Wu Jun of the Advanced Study Institute of State Food and Drug Administration, quality director Cao Yang of Pfizer （Wuxi ）Pharmaceutical Co., Ltd and representatives from over one hundred pharmaceutical factories. The director of Wuxi Drug Administration and the president of Wuxi Medicine Committee Xie Shoukun and the chairman Hua Guoping of Jiangsu Hualan New Pharmaceutical Material Co., Ltd attended the forum and made speeches.
In the forum, the president Xie Shoukun extended warm welcome to the coming of all leaders, experts and colleagues and expressed thanks to the coordination of Hualan NPM. Present Xie stated the Taihu Lake Medicine Quality Assurance Forum had always adhered to the characteristics of public welfare, openness and speciality since being held and combined publicity and implementation of GMP with check and certification and daily supervision from the beginning, giving play to the effective strength of the forum organically, providing an exchange platform for scientific and technical personnel to implement GMP practice in time and doing service work for drug manufacturing enterprises actively and effectively. President Xie also specially emphasized how to roundly strength personnel training of the the entire personnel in the whole course in future, especially to strength the training of pharmaceutical management personnel, which is the key of the GMP fully implement.
The forum was carried on with “New Version GMP Authentication” as the center. The guest professor Wu Jun of the Advanced Study Institute of State Food and Drug Administration gave a special lecture on “Analysis and Countermeasure for Sterile Preparation Company New Version GMP Authentication Bottleneck”, covering the status quo and bottleneck of new version GMP authentication, sterile appendix- principle and difficult points in respect of relevant clauses and requirement of manufacturing management and the strategy and method of GMP file system establishment. The quality director Cao Yang of Pfizer （Wuxi ）Pharmaceutical Co., Ltd gave a special lecture on drug GMP authentication experience, mainly stating some focuses of the new version GMP authentication on-site inspection. The representatives of all pharmaceutical factories also presented their opinions and discussed intensively.
The holding of the forum received consistent praise from the experts and representatives of the pharmaceutical companies. Through exchange study and training, the experts and representatives of the pharmaceutical companies further graspd the essence of GMP, obtaining clearer thought for the following GMP authentication.
江苏华兰药用新材料股份有限公司 
